Share Price and Basic Stock Data
Last Updated: November 20, 2025, 10:02 pm
| PEG Ratio | 0.73 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Danlaw Technologies India Ltd operates within the IT Consulting and Software sector, focusing on providing technology solutions. The company’s share price stood at ₹858, with a market capitalization of ₹418 Cr. Revenue from operations has demonstrated a robust upward trend, increasing from ₹122 Cr in March 2022 to ₹167 Cr in March 2023, and further projected to rise to ₹218 Cr by March 2025. This growth trajectory reflects an annual compound growth rate of approximately 32% over the two-year period. Quarterly sales figures also show significant quarterly increases, with sales rising from ₹37.35 Cr in June 2022 to ₹50.05 Cr in September 2023. The latest reported sales for December 2023 stood at ₹53.02 Cr, indicating strong demand for its services. The company’s operating profit margin (OPM) was recorded at 12.67%, which is competitive for the IT consulting sector, where margins typically range from 10% to 20%, suggesting that Danlaw Technologies is effectively managing its operational costs while capitalizing on revenue growth.
Profitability and Efficiency Metrics
Danlaw Technologies reported a net profit of ₹20 Cr for the fiscal year ending March 2025, demonstrating a healthy increase from ₹7 Cr in March 2023. This growth in net profit is complemented by a robust return on equity (ROE) of 28.3% and return on capital employed (ROCE) of 28.0%, both of which significantly exceed industry averages, typically ranging from 15% to 20%. The company’s interest coverage ratio (ICR) stood at 6.52x, indicating a strong ability to cover interest obligations, which is favorable compared to industry norms. The cash conversion cycle (CCC) of 113 days suggests that the company has a moderate working capital management cycle, which is critical for maintaining liquidity. The operating profit margin (OPM) of 12.67% reflects efficient cost control measures, particularly as the company has also managed to maintain its operating profit at 15% to 17% in recent quarters. Overall, these profitability metrics highlight Danlaw Technologies’ effective operational efficiency and financial health.
Balance Sheet Strength and Financial Ratios
Danlaw Technologies maintains a strong balance sheet, with no reported borrowings, which positions the company favorably in terms of financial leverage. The price-to-book value (P/BV) ratio is reported at 2.70x, indicating that the market values the company at a premium relative to its book value. This premium often reflects investor confidence in the company’s growth prospects and profitability. The interest coverage ratio (ICR) of 6.52x further emphasizes the company’s capacity to manage its debt obligations effectively. The reported reserves are not available, which may limit insights into retained earnings but do not detract from the overall financial stability indicated by the absence of debt. Efficiency ratios such as the inventory turnover ratio of 4.65x demonstrate that the company is managing its inventory effectively, which is crucial in the IT services space where project deliveries can be time-sensitive. Overall, the balance sheet reflects a solid financial foundation that supports future growth initiatives.
Shareholding Pattern and Investor Confidence
As of September 2023, Danlaw Technologies has a diverse shareholding structure, with promoters holding 61.87% of the shares, which provides a strong alignment of interests between management and shareholders. The public holds 37.23% of the shares, indicating a healthy level of retail investor interest. Notably, foreign institutional investors (FIIs) hold 0.00%, suggesting limited international exposure, which could either be a risk or an opportunity for future investment inflow. The number of shareholders has shown a steady increase, from 3,584 in December 2022 to 8,756 by September 2025, reflecting growing investor confidence in the company’s performance. This increasing trend in shareholder numbers indicates a positive sentiment towards the company’s growth potential and financial stability. The absence of dividends, however, may raise questions for some investors looking for income generation, but it also suggests a focus on reinvesting profits for growth.
Outlook, Risks, and Final Insight
Looking ahead, Danlaw Technologies is well-positioned to capitalize on the growing demand for IT consulting and software services, with projected revenues set to reach ₹218 Cr by March 2025. However, potential risks include the company’s reliance on domestic markets, as indicated by the 0.00% foreign institutional investment, which may limit exposure to global growth opportunities. Additionally, while the absence of debt strengthens the balance sheet, it may also indicate a conservative approach to leveraging opportunities for expansion. The increasing competition in the IT sector could also pose challenges to maintaining profitability and market share. Nonetheless, the strong financial metrics, including a high ROE and ICR, provide a solid foundation for navigating these risks. Overall, Danlaw Technologies presents a compelling investment case, driven by robust growth metrics and operational efficiency, but investors should remain vigilant regarding industry dynamics and market conditions.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Danlaw Technologies India Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Naapbooks Ltd | 160 Cr. | 148 | 194/99.8 | 24.4 | 36.4 | 0.00 % | 23.6 % | 17.1 % | 10.0 |
| IB Infotech Enterprises Ltd | 27.9 Cr. | 218 | 310/140 | 19.9 | 26.7 | 0.46 % | 38.5 % | 35.4 % | 10.0 |
| Hit Kit Global Solutions Ltd | 5.52 Cr. | 1.13 | 1.73/0.91 | 2.47 | 0.00 % | 2.14 % | 2.15 % | 2.00 | |
| Globalspace Technologies Ltd | 57.4 Cr. | 16.7 | 25.0/13.7 | 103 | 15.8 | 0.00 % | 2.13 % | 1.41 % | 10.0 |
| First Fintec Ltd | 7.09 Cr. | 6.82 | 11.7/5.25 | 88.6 | 10.3 | 0.00 % | 0.28 % | 0.85 % | 10.0 |
| Industry Average | 20,256.89 Cr | 585.07 | 92.12 | 126.08 | 0.55% | 14.93% | 20.42% | 6.95 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 37.35 | 37.99 | 43.55 | 48.25 | 46.39 | 50.05 | 53.02 | 61.52 | 47.30 | 54.58 | 54.69 | 62.31 | 54.77 |
| Expenses | 34.88 | 34.56 | 37.79 | 39.82 | 39.74 | 40.81 | 43.27 | 50.90 | 41.38 | 47.00 | 46.93 | 51.77 | 47.83 |
| Operating Profit | 2.47 | 3.43 | 5.76 | 8.43 | 6.65 | 9.24 | 9.75 | 10.62 | 5.92 | 7.58 | 7.76 | 10.54 | 6.94 |
| OPM % | 6.61% | 9.03% | 13.23% | 17.47% | 14.33% | 18.46% | 18.39% | 17.26% | 12.52% | 13.89% | 14.19% | 16.92% | 12.67% |
| Other Income | 0.40 | 0.27 | 0.02 | 0.07 | 0.09 | 0.03 | 0.03 | 0.13 | 0.22 | 0.27 | 0.23 | 0.25 | 0.29 |
| Interest | 0.68 | 0.80 | 0.91 | 0.88 | 0.61 | 0.63 | 0.63 | 0.59 | 0.54 | 0.62 | 0.57 | 0.54 | 0.52 |
| Depreciation | 1.04 | 1.13 | 1.20 | 3.74 | 1.22 | 0.92 | 0.93 | 0.93 | 0.94 | 1.33 | 1.40 | 1.44 | 2.02 |
| Profit before tax | 1.15 | 1.77 | 3.67 | 3.88 | 4.91 | 7.72 | 8.22 | 9.23 | 4.66 | 5.90 | 6.02 | 8.81 | 4.69 |
| Tax % | 25.22% | 29.94% | 24.80% | 38.66% | 25.46% | 23.32% | 26.76% | 28.17% | 25.75% | 23.39% | 26.74% | 25.99% | 25.80% |
| Net Profit | 0.86 | 1.24 | 2.76 | 2.38 | 3.66 | 5.92 | 6.03 | 6.62 | 3.47 | 4.52 | 4.41 | 6.52 | 3.47 |
| EPS in Rs | 2.32 | 3.34 | 5.67 | 4.89 | 7.51 | 12.15 | 12.38 | 13.59 | 7.12 | 9.28 | 9.05 | 13.39 | 7.12 |
Last Updated: August 19, 2025, 8:30 pm
Below is a detailed analysis of the quarterly data for Danlaw Technologies India Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 54.77 Cr.. The value appears to be declining and may need further review. It has decreased from 62.31 Cr. (Mar 2025) to 54.77 Cr., marking a decrease of 7.54 Cr..
- For Expenses, as of Jun 2025, the value is 47.83 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 51.77 Cr. (Mar 2025) to 47.83 Cr., marking a decrease of 3.94 Cr..
- For Operating Profit, as of Jun 2025, the value is 6.94 Cr.. The value appears to be declining and may need further review. It has decreased from 10.54 Cr. (Mar 2025) to 6.94 Cr., marking a decrease of 3.60 Cr..
- For OPM %, as of Jun 2025, the value is 12.67%. The value appears to be declining and may need further review. It has decreased from 16.92% (Mar 2025) to 12.67%, marking a decrease of 4.25%.
- For Other Income, as of Jun 2025, the value is 0.29 Cr.. The value appears strong and on an upward trend. It has increased from 0.25 Cr. (Mar 2025) to 0.29 Cr., marking an increase of 0.04 Cr..
- For Interest, as of Jun 2025, the value is 0.52 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.54 Cr. (Mar 2025) to 0.52 Cr., marking a decrease of 0.02 Cr..
- For Depreciation, as of Jun 2025, the value is 2.02 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1.44 Cr. (Mar 2025) to 2.02 Cr., marking an increase of 0.58 Cr..
- For Profit before tax, as of Jun 2025, the value is 4.69 Cr.. The value appears to be declining and may need further review. It has decreased from 8.81 Cr. (Mar 2025) to 4.69 Cr., marking a decrease of 4.12 Cr..
- For Tax %, as of Jun 2025, the value is 25.80%. The value appears to be improving (decreasing) as expected. It has decreased from 25.99% (Mar 2025) to 25.80%, marking a decrease of 0.19%.
- For Net Profit, as of Jun 2025, the value is 3.47 Cr.. The value appears to be declining and may need further review. It has decreased from 6.52 Cr. (Mar 2025) to 3.47 Cr., marking a decrease of 3.05 Cr..
- For EPS in Rs, as of Jun 2025, the value is 7.12. The value appears to be declining and may need further review. It has decreased from 13.39 (Mar 2025) to 7.12, marking a decrease of 6.27.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: November 15, 2025, 3:33 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 8 | 9 | 11 | 11 | 18 | 26 | 15 | 28 | 122 | 167 | 211 | 218 | 237 |
| Expenses | 9 | 8 | 9 | 11 | 17 | 26 | 19 | 30 | 115 | 147 | 174 | 186 | 203 |
| Operating Profit | -0 | 0 | 2 | 1 | 1 | 0 | -3 | -2 | 6 | 20 | 36 | 32 | 35 |
| OPM % | -5% | 3% | 15% | 6% | 6% | 0% | -21% | -9% | 5% | 12% | 17% | 15% | 15% |
| Other Income | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 5 | 1 | 0 | 1 | 1 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 4 | 3 | 2 | 2 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 2 | 4 | 7 | 4 | 5 | 7 |
| Profit before tax | 1 | 1 | 3 | 2 | 2 | 0 | -4 | -4 | 5 | 10 | 30 | 25 | 27 |
| Tax % | 35% | 20% | 32% | 222% | 30% | 29% | -24% | -27% | 14% | 31% | 26% | 26% | |
| Net Profit | 0 | 1 | 2 | -2 | 1 | 0 | -3 | -3 | 4 | 7 | 22 | 19 | 20 |
| EPS in Rs | 1.08 | 2.53 | 5.11 | -5.27 | 3.02 | 0.84 | -8.82 | -7.26 | 11.54 | 14.88 | 45.64 | 38.84 | 40.85 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
YoY Net Profit Growth
| Year | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 100.00% | -200.00% | 150.00% | -100.00% | 0.00% | 233.33% | 75.00% | 214.29% | -13.64% |
| Change in YoY Net Profit Growth (%) | 0.00% | -300.00% | 350.00% | -250.00% | 100.00% | 233.33% | -158.33% | 139.29% | -227.92% |
Danlaw Technologies India Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 9 years from 2015-2016 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 38% |
| 5 Years: | 70% |
| 3 Years: | 22% |
| TTM: | 7% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 35% |
| 5 Years: | 51% |
| 3 Years: | 122% |
| TTM: | -14% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 41% |
| 5 Years: | 71% |
| 3 Years: | 61% |
| 1 Year: | -46% |
| Return on Equity | |
|---|---|
| 10 Years: | 15% |
| 5 Years: | 25% |
| 3 Years: | 33% |
| Last Year: | 28% |
Last Updated: September 5, 2025, 3:06 pm
No data available for the Balance Sheet data table.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 38 | 71 | 71 | 170 | 275 | 87 | 88 | 47 | 55 | 66 | 60 | 82 |
| Inventory Days | 110 | 188 | 123 | 97 | 97 | 54 | 44 | 22 | 130 | 116 | 117 | 105 |
| Days Payable | 10 | 70 | 68 | 22 | 220 | 178 | 196 | 70 | 68 | 64 | 65 | 74 |
| Cash Conversion Cycle | 138 | 190 | 127 | 245 | 152 | -36 | -65 | -1 | 117 | 118 | 111 | 113 |
| Working Capital Days | 72 | 96 | 81 | 181 | 221 | 28 | -170 | -128 | 62 | 69 | 61 | 60 |
| ROCE % | 3% | 5% | 12% | 7% | 7% | 2% | -17% | -16% | 8% | 21% | 40% | 28% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 22 | Mar 21 | Mar 20 | Mar 19 | Mar 18 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 11.07 | 0.84 | -12.23 | -1.31 | 3.87 |
| Diluted EPS (Rs.) | 11.07 | 0.84 | -12.23 | -1.31 | 3.86 |
| Cash EPS (Rs.) | 22.31 | 14.93 | -5.39 | 0.56 | 4.38 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 77.06 | 74.64 | 71.67 | 84.07 | 70.37 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 77.06 | 74.64 | 71.67 | 84.07 | 70.37 |
| Revenue From Operations / Share (Rs.) | 327.93 | 266.70 | 147.94 | 147.98 | 52.81 |
| PBDIT / Share (Rs.) | 28.59 | 20.23 | -8.15 | 0.01 | 5.93 |
| PBIT / Share (Rs.) | 17.50 | 9.60 | -16.79 | -3.02 | 5.43 |
| PBT / Share (Rs.) | 13.12 | 7.18 | -17.97 | -3.08 | 5.41 |
| Net Profit / Share (Rs.) | 11.22 | 4.31 | -14.04 | -2.46 | 3.87 |
| NP After MI And SOA / Share (Rs.) | 11.07 | 0.83 | -12.23 | -1.31 | 3.87 |
| PBDIT Margin (%) | 8.71 | 7.58 | -5.50 | 0.00 | 11.23 |
| PBIT Margin (%) | 5.33 | 3.60 | -11.35 | -2.04 | 10.27 |
| PBT Margin (%) | 4.00 | 2.69 | -12.14 | -2.07 | 10.24 |
| Net Profit Margin (%) | 3.42 | 1.61 | -9.48 | -1.66 | 7.33 |
| NP After MI And SOA Margin (%) | 3.37 | 0.31 | -8.26 | -0.88 | 7.33 |
| Return on Networth / Equity (%) | 17.94 | 1.40 | -20.41 | -1.86 | 5.50 |
| Return on Capital Employeed (%) | 11.19 | 7.66 | -16.92 | -3.16 | 7.71 |
| Return On Assets (%) | 4.62 | 0.38 | -6.78 | -0.86 | 4.58 |
| Long Term Debt / Equity (X) | 0.18 | 0.08 | 0.00 | 0.00 | 0.00 |
| Total Debt / Equity (X) | 0.47 | 0.30 | 0.00 | 0.00 | 0.00 |
| Asset Turnover Ratio (%) | 0.91 | 0.55 | 0.32 | 0.78 | 0.66 |
| Current Ratio (X) | 1.81 | 1.39 | 1.25 | 1.92 | 5.70 |
| Quick Ratio (X) | 0.88 | 0.95 | 0.89 | 1.44 | 5.35 |
| Inventory Turnover Ratio (X) | 4.65 | 3.08 | 1.09 | 7.00 | 5.37 |
| Interest Coverage Ratio (X) | 6.52 | 8.35 | -6.92 | 0.09 | 350.15 |
| Interest Coverage Ratio (Post Tax) (X) | 3.56 | 2.78 | -10.91 | -43.07 | 229.58 |
| Enterprise Value (Cr.) | 74.29 | 110.42 | 8.44 | 32.43 | 17.12 |
| EV / Net Operating Revenue (X) | 0.61 | 1.12 | 0.15 | 0.59 | 0.87 |
| EV / EBITDA (X) | 7.01 | 14.72 | -2.79 | 16299.71 | 7.78 |
| MarketCap / Net Operating Revenue (X) | 0.50 | 1.02 | 0.17 | 0.62 | 1.33 |
| Price / BV (X) | 2.70 | 4.59 | 0.43 | 1.31 | 0.99 |
| Price / Net Operating Revenue (X) | 0.50 | 1.02 | 0.17 | 0.62 | 1.33 |
| EarningsYield | 0.06 | 0.00 | -0.47 | -0.01 | 0.05 |
After reviewing the key financial ratios for Danlaw Technologies India Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 22, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 21) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 22, the value is 11.07. This value is within the healthy range. It has increased from 0.84 (Mar 21) to 11.07, marking an increase of 10.23.
- For Diluted EPS (Rs.), as of Mar 22, the value is 11.07. This value is within the healthy range. It has increased from 0.84 (Mar 21) to 11.07, marking an increase of 10.23.
- For Cash EPS (Rs.), as of Mar 22, the value is 22.31. This value is within the healthy range. It has increased from 14.93 (Mar 21) to 22.31, marking an increase of 7.38.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 22, the value is 77.06. It has increased from 74.64 (Mar 21) to 77.06, marking an increase of 2.42.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 22, the value is 77.06. It has increased from 74.64 (Mar 21) to 77.06, marking an increase of 2.42.
- For Revenue From Operations / Share (Rs.), as of Mar 22, the value is 327.93. It has increased from 266.70 (Mar 21) to 327.93, marking an increase of 61.23.
- For PBDIT / Share (Rs.), as of Mar 22, the value is 28.59. This value is within the healthy range. It has increased from 20.23 (Mar 21) to 28.59, marking an increase of 8.36.
- For PBIT / Share (Rs.), as of Mar 22, the value is 17.50. This value is within the healthy range. It has increased from 9.60 (Mar 21) to 17.50, marking an increase of 7.90.
- For PBT / Share (Rs.), as of Mar 22, the value is 13.12. This value is within the healthy range. It has increased from 7.18 (Mar 21) to 13.12, marking an increase of 5.94.
- For Net Profit / Share (Rs.), as of Mar 22, the value is 11.22. This value is within the healthy range. It has increased from 4.31 (Mar 21) to 11.22, marking an increase of 6.91.
- For NP After MI And SOA / Share (Rs.), as of Mar 22, the value is 11.07. This value is within the healthy range. It has increased from 0.83 (Mar 21) to 11.07, marking an increase of 10.24.
- For PBDIT Margin (%), as of Mar 22, the value is 8.71. This value is below the healthy minimum of 10. It has increased from 7.58 (Mar 21) to 8.71, marking an increase of 1.13.
- For PBIT Margin (%), as of Mar 22, the value is 5.33. This value is below the healthy minimum of 10. It has increased from 3.60 (Mar 21) to 5.33, marking an increase of 1.73.
- For PBT Margin (%), as of Mar 22, the value is 4.00. This value is below the healthy minimum of 10. It has increased from 2.69 (Mar 21) to 4.00, marking an increase of 1.31.
- For Net Profit Margin (%), as of Mar 22, the value is 3.42. This value is below the healthy minimum of 5. It has increased from 1.61 (Mar 21) to 3.42, marking an increase of 1.81.
- For NP After MI And SOA Margin (%), as of Mar 22, the value is 3.37. This value is below the healthy minimum of 8. It has increased from 0.31 (Mar 21) to 3.37, marking an increase of 3.06.
- For Return on Networth / Equity (%), as of Mar 22, the value is 17.94. This value is within the healthy range. It has increased from 1.40 (Mar 21) to 17.94, marking an increase of 16.54.
- For Return on Capital Employeed (%), as of Mar 22, the value is 11.19. This value is within the healthy range. It has increased from 7.66 (Mar 21) to 11.19, marking an increase of 3.53.
- For Return On Assets (%), as of Mar 22, the value is 4.62. This value is below the healthy minimum of 5. It has increased from 0.38 (Mar 21) to 4.62, marking an increase of 4.24.
- For Long Term Debt / Equity (X), as of Mar 22, the value is 0.18. This value is below the healthy minimum of 0.2. It has increased from 0.08 (Mar 21) to 0.18, marking an increase of 0.10.
- For Total Debt / Equity (X), as of Mar 22, the value is 0.47. This value is within the healthy range. It has increased from 0.30 (Mar 21) to 0.47, marking an increase of 0.17.
- For Asset Turnover Ratio (%), as of Mar 22, the value is 0.91. It has increased from 0.55 (Mar 21) to 0.91, marking an increase of 0.36.
- For Current Ratio (X), as of Mar 22, the value is 1.81. This value is within the healthy range. It has increased from 1.39 (Mar 21) to 1.81, marking an increase of 0.42.
- For Quick Ratio (X), as of Mar 22, the value is 0.88. This value is below the healthy minimum of 1. It has decreased from 0.95 (Mar 21) to 0.88, marking a decrease of 0.07.
- For Inventory Turnover Ratio (X), as of Mar 22, the value is 4.65. This value is within the healthy range. It has increased from 3.08 (Mar 21) to 4.65, marking an increase of 1.57.
- For Interest Coverage Ratio (X), as of Mar 22, the value is 6.52. This value is within the healthy range. It has decreased from 8.35 (Mar 21) to 6.52, marking a decrease of 1.83.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 22, the value is 3.56. This value is within the healthy range. It has increased from 2.78 (Mar 21) to 3.56, marking an increase of 0.78.
- For Enterprise Value (Cr.), as of Mar 22, the value is 74.29. It has decreased from 110.42 (Mar 21) to 74.29, marking a decrease of 36.13.
- For EV / Net Operating Revenue (X), as of Mar 22, the value is 0.61. This value is below the healthy minimum of 1. It has decreased from 1.12 (Mar 21) to 0.61, marking a decrease of 0.51.
- For EV / EBITDA (X), as of Mar 22, the value is 7.01. This value is within the healthy range. It has decreased from 14.72 (Mar 21) to 7.01, marking a decrease of 7.71.
- For MarketCap / Net Operating Revenue (X), as of Mar 22, the value is 0.50. This value is below the healthy minimum of 1. It has decreased from 1.02 (Mar 21) to 0.50, marking a decrease of 0.52.
- For Price / BV (X), as of Mar 22, the value is 2.70. This value is within the healthy range. It has decreased from 4.59 (Mar 21) to 2.70, marking a decrease of 1.89.
- For Price / Net Operating Revenue (X), as of Mar 22, the value is 0.50. This value is below the healthy minimum of 1. It has decreased from 1.02 (Mar 21) to 0.50, marking a decrease of 0.52.
- For EarningsYield, as of Mar 22, the value is 0.06. This value is below the healthy minimum of 5. It has increased from 0.00 (Mar 21) to 0.06, marking an increase of 0.06.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
Unable to fetch valid data for stock valuation.Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Danlaw Technologies India Ltd:
- Net Profit Margin: 3.42%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 11.19% (Industry Average ROCE: 14.93%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 17.94% (Industry Average ROE: 20.42%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 3.56
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.88
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 21 (Industry average Stock P/E: 92.12)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.47
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 3.42%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| IT Consulting & Software | Unit No. 201,202 & 203, Gowra Fountainhead, Hyderabad Telangana 500081 | info@danlawtechnologies.com http://www.danlawtechnologies.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Raju S Dandu | Chairman & Wholetime Director |
| Mr. Shireesh Shantaram Phal | Executive Director |
| Mr. M A Ashok Kumar | Independent Director |
| Mr. Venigalla Sambasivarao | Independent Director |
| Mr. Indraganty Venkateswara Sarma | Independent Director |
| Mr. Putrevu Seshagiri Rao | Independent Director |
| Mr. Timothy Matthew Morris | Director |
| Ms. M Sridevi | Woman Director |